Skip to main content
Qiagen's CMV assay on QiaSymphony platform OK'd by FDA
6/7/2017

Qiagen has obtained premarket approval from the FDA for its Artus CMV QS-RGQ molecular diagnostic kit on the fully automated, sample-to-answer QiaSymphony platform. The real-time PCR assay, which is intended for use with human plasma samples, helps manage solid organ transplant patients who are on anti-cytomegalovirus therapy.

Full Story: